Cited by 196Ovarian function and disordersEndometriosis Research and TreatmentReproductive Biology and Fertility

The DOI matches its Crossref record; 81 of the 83 references it cites were found in a registry or an index.

A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines

Open access

Neven, Adriana, Laven, Joop, Teede, Helena, Boyle, Jacqueline·2018·Seminars in Reproductive Medicine

Open this paper in CoChat — free account Open PDF

Abstract

Polycystic ovary syndrome (PCOS) is a common hormonal condition with reproductive, metabolic, and psychological sequelae. The Rotterdam Criteria are now internationally accepted, with different phenotypes recognized with varying clinical presentations and risk profiles. The complexity of the disorder, and the impact on quality of life, requires timely diagnosis, screening for complications and management strategies. PCOS remains underdiagnosed and women experience significant delays to diagnosis. Effective dissemination of evidence-based management is therefore vital. In this review, we summarize key aspects of PCOS as a prelude to this issue of Seminars in Reproductive Medicine on PCOS which focuses on the development of the international evidence-based guideline on the assessment and management of PCOS and the related translation program. We cover diagnostic criteria, prevalence, phenotypes, reproductive, metabolic, and psychological factors of PCOS. We also cover management strategies including lifestyle interventions as well as treatment of nonreproductive outcomes and reproductive outcomes informed by the latest international evidence-based guidelines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1055/s-0038-1668085

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Men at risk: occupation and male infertility.
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients
Balen, A. H., Conway, G. S., Kaltsas, G., Techatraisak, K., Manning, P. J., West, C., & Jacobs, H. S. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136243 · Cited by 1,060
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Self-citation
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Self-citation
The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global who guidance
Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705
Self-citation

Show all 83 references

Research works printed but not linked: 1

Teede HJ, Misso ML, Costello MF, et al. Norman RJ on behalf of the International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; In press

Sorted by citations

Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener‐Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 391
Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S. S., Alycia, C., Pirotta, S., Thomson, R. L., Gibson‐Helm, M. E., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 322
Characteristics of polycystic ovary syndrome throughout life
Louwers, Y. V., & Laven, J. S. E. (2020) · Therapeutic Advances in Reproductive Health · doi:10.1177/2633494120911038 · Cited by 204
Self-citation
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
Newman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 182
Infertility management in women with polycystic ovary syndrome: a review
Cunha, A., & Póvoa, A. M. (2021) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000116 · Cited by 123
Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS
Rudnicka, E., Kunicki, M., Calik-Ksepka, A., Suchta, K., Duszewska, A. M., Smolarczyk, K., & Smolarczyk, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212507 · Cited by 141
DNA methylation in the pathogenesis of polycystic ovary syndrome
Vázquez-Martínez, E. R., Gómez-Viais, Y. I., García-Gómez, E., Reyes-Mayoral, C., Reyes-Muñoz, E., Camacho‐Arroyo, I., & Cerbón, M. A. (2019) · Reproduction · doi:10.1530/rep-18-0449 · Cited by 111
The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Guan, Y., Wang, D., Bu, H., Zhao, T., & Wang, H. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5150684 · Cited by 109
Polycystic ovary syndrome phenotypes and prevalence: Differential impact of diagnostic criteria and clinical versus unselected population
Mümüşoğlu, S., & Yıldız, B. O. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.03.004 · Cited by 107
Polycystic Ovarian Syndrome
Shrivastava, S., & Conigliaro, R. L. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.10.004 · Cited by 95
Pathological pulses in PCOS
Coyle, C., & Campbell, R. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110561 · Cited by 89
Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models
Laws, M. J., Neff, A. M., Brehm, E., Warner, G. R., & Flaws, J. A. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.008 · Cited by 85
Role of Lipid Metabolism and Signaling in Mammalian Oocyte Maturation, Quality, and Acquisition of Competence
Khan, R., Jiang, X., Hameed, U., & Shi, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639704 · Cited by 85
An update of polycystic ovary syndrome: causes and therapeutics options
Rababa’h, A. M., Matani, B. R., & Yehya, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11010 · Cited by 90
Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life
Greydanus, D. E., Azmeh, R., Cabral, M. D., Dickson, C. A., & Patel, D. R. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.101103 · Cited by 77
An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options
Islam, H., Masud, J., Islam, Y. N., & Haque, F. K. M. (2022) · Women s Health · doi:10.1177/17455057221117966 · Cited by 98
Acupuncture regulates the autophagy of ovarian granulosa cells in polycystic ovarian syndrome ovulation disorder by inhibiting the PI3K/AKT/mTOR pathway through LncMEG3
Chen, X., Tang, H., Liang, Y., Wu, P., Xie, L., Ding, Y., Yang, P., Long, B., & Lin, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112288 · Cited by 61
Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe
Piltonen, T. T., Ruokojärvi, M., Karro, H., Kujanpää, L., Morin-Papunen, L., Tapanainen, J. S., Stener-Victorin, E., Sundrström-Poromaa, I., Hirschberg, A. L., Ravn, P., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0226074 · Cited by 58
Self-citation
Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats
Tao, X., Cai, L., Chen, L., Ge, S., & Deng, X. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0555-8 · Cited by 60
Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
Ganie, M. A., Sahar, T., Rashid, A., Wani, I. A., Nisar, S., Sathyapalan, T., Vishnubhatla, S., Ramakrishnan, L., Parvez, T., & Geer, M. I. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00699 · Cited by 58
The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients
Yang, Y., Xia, J., Yang, Z., Wu, G., & Yang, J. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00867-0 · Cited by 49
Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue
Zhang, Y., Lin, Y., Li, G., Yuan, Y., Wang, X., Li, N., Xiong, C., Yang, Y., Ma, Y., Zhang, Z., et al. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad032 · Cited by 49
Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application
Abbott, D. H., Rogers, J., Dumesic, D. A., & Levine, J. E. (2019) · Medical Sciences · doi:10.3390/medsci7120107 · Cited by 42
What can be done to improve polycystic ovary syndrome (PCOS) healthcare? Insights from semi-structured interviews with women in Canada
Ismayilova, M., & Yaya, S. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01734-w · Cited by 40
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
Pani, A., Gironi, I., Di Vieste, G., Mion, E., Bertuzzi, F., & Pintaudi, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/6276187 · Cited by 38
N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2
Zhou, L., Han, X., Li, W., Wang, N., Yao, L., Zhao, Y., & Zhang, L. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00664-6 · Cited by 41
Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study
van Keizerswaard, J., de Loos, A. D., Louwers, Y. V., & Laven, J. S. E. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.01.014 · Cited by 42
Self-citation
Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/ XIAP axis
Lu, X., Gao, H., Zhu, B., & Lin, G. (2021) · Bioengineered · doi:10.1080/21655979.2021.1964157 · Cited by 37
Transcriptional and DNA Methylation Signatures of Subcutaneous Adipose Tissue and Adipose-Derived Stem Cells in PCOS Women
Divoux, A., Erdős, E., Whytock, K. L., Osborne, T. F., & Smith, S. R. (2022) · Cells · doi:10.3390/cells11050848 · Cited by 40
Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome
Moolhuijsen, L. M. E., Louwers, Y. V., Laven, J. S. E., & Visser, J. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac370 · Cited by 36
Self-citation
Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome
van der Ham, K., Moolhuijsen, L. M. E., Brewer, K., Sisk, R. K., Dunaif, A. E., Laven, J. S. E., Louwers, Y. V., & Visser, J. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae298 · Cited by 41
Self-citation
Effect of Yoga Therapy on Health Outcomes in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Verma, A., Upadhyay, V., & Saxena, V. (2021) · American Journal of Lifestyle Medicine · doi:10.1177/15598276211029221 · Cited by 34
Changes in Resting-State Cerebral Activity in Women With Polycystic Ovary Syndrome: A Functional MR Imaging Study
Li, G., Hu, J., Zhang, S., Fan, W., Wen, L., Wang, G., & Zhang, D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.603279 · Cited by 32
Association between Body Mass Index and Reproductive Outcome in Women with Polycystic Ovary Syndrome Receiving IVF/ICSI‐ET
Zhou, H., Zhang, D., Luo, Z., Yang, A., Cui, N., Hao, G., & Wang, W. (2020) · BioMed Research International · doi:10.1155/2020/6434080 · Cited by 31
Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
Moin, A. S. M., Sathyapalan, T., Diboun, I., Elrayess, M. A., Butler, A. E., & Atkin, S. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-84586-y · Cited by 31
Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records
Actkins, K. V., Singh, K., Hucks, D., Velez Edwards, D. R., Aldrich, M., Cha, J., Wellons, M., & Davis, L. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa675 · Cited by 27
Quercetin and polycystic ovary syndrome
Ma, C., Xiang, Q., Song, G., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1006678 · Cited by 36
Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients
Moolhuijsen, L. M. E., Louwers, Y. V., McLuskey, A., Broer, L., Uitterlinden, A. G., Verdiesen, R. M. G., Sisk, R. K., Dunaif, A. E., Laven, J. S. E., & Visser, J. A. (2022) · Human Reproduction · doi:10.1093/humrep/deac082 · Cited by 29
Self-citation
Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
Zhang, Q., Ye, R., Zhang, Y., Fan, C.-C., Wang, J., Wang, S., Chen, S., & Liu, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.847249 · Cited by 29
Nutrient Patterns and Risk of Polycystic Ovary Syndrome.
(2019) · Europe PMC (PubMed Central) · Cited by 27
Morphological evidence indicates a role for microglia in shaping the PCOS‐like brain
Sati, A., Prescott, M., Holland, S., Jasoni, C. L., Desroziers, E., & Campbell, R. E. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12999 · Cited by 27
The Need to Reassess the Diagnosis of Polycystic Ovary Syndrome (PCOS): A Review of Diagnostic Recommendations from the International Evidence-Based Guideline for the Assessment and Management of PCOS
Kiconco, S., Teede, H. J., Azziz, R., Norman, R. J., & Joham, A. E. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1735259 · Cited by 26
Self-citation
Natural history of polycystic ovary syndrome: A systematic review of cardiometabolic outcomes from longitudinal cohort studies
Kiconco, S., Tay, C. T., Rassie, K. L., Azziz, R., Teede, H. J., & Joham, A. E. (2022) · Clinical Endocrinology · doi:10.1111/cen.14647 · Cited by 25
Self-citation
PCOS Phenotype in Unselected Populations Study (P-PUP): Protocol for a Systematic Review and Defining PCOS Diagnostic Features with Pooled Individual Participant Data
Kiconco, S., Mousa, A., Azziz, R., Enticott, J., Сутурина, Л. В., Zhao, X., Gambineri, A., Tehrani, F. R., Yıldız, B. O., Kim, J., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11111953 · Cited by 24
Self-citation
Specific Alteration of Branched-Chain Amino Acid Profile in Polycystic Ovary Syndrome
Paczkowska, K., Rachoń, D., Berg, A., Rybka, J., Kapczyńska, K., Bolanowski, M., & Daroszewski, J. (2023) · Biomedicines · doi:10.3390/biomedicines11010108 · Cited by 25
Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome
Liu, L., He, D., Wang, Y., & Sheng, M. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11005 · Cited by 24
A diagnostic model for polycystic ovary syndrome based on machine learning
Tong, C., Wu, Y., Zhuang, Z., & Ying, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-92630-4 · Cited by 23
MicroRNA‑874‑3p promotes testosterone‑induced granulosa cell apoptosis by suppressing HDAC1‑mediated p53 deacetylation
Wei, Y., Wang, Z., Li, W., Shen, L., Qiu, X., & Liu, C. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9790 · Cited by 23
The role of Sirtuin 1 in the pathophysiology of polycystic ovary syndrome
Wu, M., Zhang, J., Gu, R., Dai, F., Yang, D., Zheng, Y., Tan, W., Jia, Y., Li, B., & Cheng, Y. (2022) · European journal of medical research · doi:10.1186/s40001-022-00746-4 · Cited by 24
N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway
Jing, Y.-X., Li, H., Yue, F., Li, Y., Yu, X., He, J.-J., & Zhang, X. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2276167 · Cited by 23
The effectiveness of resveratrol in treatment of PCOS on the basis of experimental model in rats
Yarmolinskaya, M. I., Bulgakova, O. L., Ивановна, А. Е., Borodina, V. L., & Tral, T. G. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.2014665 · Cited by 22
Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
Butler, A. E., Moin, A. S. M., Sathyapalan, T., & Atkin, S. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012232 · Cited by 22
Endocrine factors associated with infertility in women: an updated review
Concepción‐Zavaleta, M. J., Arroyo, J., Aldave, J. E. Q., Durand‐Vásquez, M. D. C., Ildefonso-Najarro, S. P., Rafael-Robles, L. D. P., Urteaga, L. A. C., Osorio, E. R. G., Suárez-Rojas, J., & Paz‐Ibarra, J. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2256405 · Cited by 24
The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis
Liu, J., Su, H., Jin, X., Wang, L., & Huang, J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1209614 · Cited by 23
Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats
Xing, C., Lv, B., Zhao, H., Wang, D., Li, X., & He, B. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105992 · Cited by 21
AMH in PCOS: Controlling the ovary, placenta, or brain?
Moolhuijsen, L. M. E., & Visser, J. A. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.04.006 · Cited by 20
Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
Butler, A. E., Moin, A. S. M., Sathyapalan, T., & Atkin, S. L. (2023) · Cells · doi:10.3390/cells12152002 · Cited by 19
Different pregnancy outcomes according to the polycystic ovary syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies
Chatzakis, C., Tsakmaki, E., Psomiadou, A., Charitakis, N., Eleftheriades, M. I., Dinas, K. D., Goulis, D. G., & Sotiriadis, A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.12.027 · Cited by 19
Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity
Moin, A. S. M., Sathyapalan, T., Butler, A. E., & Atkin, S. L. (2023) · Clinical Endocrinology · doi:10.1111/cen.14904 · Cited by 18
The effects of plasticizers on the ovary
Neff, A. M., & Flaws, J. A. (2021) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2021.01.004 · Cited by 18
Clinical guidelines «Polycystic Ovary Syndrome»
Adamyan, L. V., Andreeva, E. N., Absatarova, Y. S., Grigoryan, O. R., Dedov, I. I., Mel'nichenko, G. A., Сутурина, Л. В., Филиппов, О. С., Sheremetyeva, E. V., Евгеньевна, Ч. Г., et al. (2022) · Problems of Endocrinology · doi:10.14341/probl12874 · Cited by 24
The risk factors of gestational hypertension in patients with polycystic ovary syndrome: a retrospective analysis
Zhou, S., Ji, Y., & Wang, H. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03808-3 · Cited by 17
Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
Ilias, Ι., Goulas, S., & Zabulienė, L. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i12.2711 · Cited by 15
Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
Shi, M., Li, X., Xing, L., Li, Z., Zhou, S., Wang, Z., Zou, X., She, Y., Zhao, R., & Qin, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121556 · Cited by 22
Antioxidative and anti-inflammatory effects of Carvacrol against polycystic ovary syndrome associated complications using high fat diet and Letrozole challenged rat model: a multidisciplinary study cascading in vivo, in vitro, in silico and network pharmacology approaches
Siddiqua, A., Malik, A., Iqbal, U., Sial, N. T., Mehmood, M. H., & Rehman, M. F. U. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01809-8 · Cited by 16
LncRNA SNHG12 promotes cell proliferation and inhibits apoptosis of granulosa cells in polycystic ovarian syndrome by sponging miR-129 and miR-125b
Xuan, F., Jin, R., Zhou, W., Ye, Y., Ren, Y., Lu, J., & Chen, A. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01392-6 · Cited by 15
Polymorphisms of Vitamin D Receptor and the Effect on Metabolic and Endocrine Abnormalities in Polycystic Ovary Syndrome: A Review
Vulcan, T., Filip, G. A., Lenghel, L. M., Suciu, T. S., Anca, P. I., & Procopciuc, L. M. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1587-9336 · Cited by 17
RETRACTED ARTICLE: High levels of fatty acid-binding protein 5 excessively enhances fatty acid synthesis and proliferation of granulosa cells in polycystic ovary syndrome
Liu, J., Li, J., Wu, X., Zhang, M., Yan, G., Sun, H., & Li, D. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01368-6 · Cited by 14
Retracted
Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling
Romero‐Ruíz, A., Pineda, B., Ovelleiro, D., Perdices-López, C., Torres, E., Vazquez, M. J., Guler, I., Jiménez, Á., Pineda, R., Persano, M., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0552 · Cited by 14
Diabetes, Polycystic Ovarian Syndrome, Obstructive Sleep Apnea, and Obesity: A Systematic Review and Important Emerging Themes.
Bambhroliya, Z., Sandrugu, J., Lowe, M., Okunlola, O. I., Raza, S., Osasan, S. A., Sethia, S., Batool, T., & Hamid, P. (2022) · PubMed Central · doi:10.7759/cureus.26325 · Cited by 17
Vitamin E supplementation improves testosterone, glucose- and lipid-related metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials
Vasquez, S. D. Y., Rosales, K. D. M. O., Nieto-Gutiérrez, W., Benites-Zapata, V. A., Pérez-López, F. R., & Alarcon-Ruiz, C. A. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2079629 · Cited by 16
High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
Butler, A. E., Moin, A. S. M., Reiner, Ž., Sathyapalan, T., Jamialahmadi, T., Sahebkar, A., & Atkin, S. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1117761 · Cited by 14
Age-related Curves of AMH Using the Gen II, the picoAMH, and the Elecsys Assays in Women With Polycystic Ovary Syndrome
Barbagallo, F., van der Ham, K., Willemsen, S. P., Louwers, Y. V., & Laven, J. S. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae153 · Cited by 13
Self-citation
HOXA10 and HOXA11 Methylation: Epigenetic Barriers to Endometrial Receptivity in ART
Kudlay, D. A., Kiselev, V. I., & Sukhikh, G. T. (2025) · Genes · doi:10.3390/genes16101230 · Cited by 12
Current Awareness Status of and Recommendations for Polycystic Ovarian Syndrome: A National Cross-Sectional Investigation of Central Jordan
Muhaidat, N., Mansour, S., Dardas, M., Qiqieh, J., Halasa, Z., Al‐Huneidy, L., AlSamhori, J. F., Rayyan, R., Aloweiwi, W., Almohtasib, J., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054018 · Cited by 17
Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway
Wang, J., Huang, Z., Cao, Z., Luo, Y., Liu, Y., Cao, H., Tang, X., & Fang, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011146 · Cited by 11
The burden of polycystic ovary syndrome-related infertility in 204 countries and territories, 1990-2021: an analysis of the global burden of disease study 2021
Zheng, L., Xu, X. L., Zhou, J.-Z., Hong, L., He, Y.-F., Fang, Y., Wang, B.-B., Chen, H., Chen, K., Yang, S.-S., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1559246 · Cited by 12
Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D
Moin, A. S. M., Sathyapalan, T., Butler, A. E., & Atkin, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.935750 · Cited by 11
The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking
Wu, M., Liu, H., Zhang, J., Dai, F., Gong, Y., & Cheng, Y. (2023) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2023.11234 · Cited by 11
Effectiveness and safety of aspirin combined with letrozole in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis
Yu, Q., Wang, Z., Su, F., & Wang, M. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-606 · Cited by 10
Ketogenic diet restores hormonal, apoptotic/proliferative balance and enhances the effect of metformin on a letrozole-induced polycystic ovary model in rats
Ahmed, A. F., Sharkawi, S. S., AbdelHameed, S. S., Bayoumi, A. M. A., Moussa, R. S., Alhakamy, N. A., Sadoun, H. A., Mansouri, R. A., El‐Moselhy, M. A., El‐Daly, M., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121285 · Cited by 10
Healthcare and research priorities for women with polycystic ovary syndrome in the UK National Health Service: A modified Delphi method
Wattar, B. H. A., Teh, J. J., Clarke, S. A., Abbara, A., Morman, R., Wilcox, A., & Talaulikar, V. S. (2024) · Clinical Endocrinology · doi:10.1111/cen.15038 · Cited by 9
Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study
Butler, A. E., Dargham, S. R., Abouseif, A., Elshewehy, A. M. M., & Atkin, S. L. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105892 · Cited by 9
Gut microbiota and polycystic ovary syndrome, focus on genetic associations: a bidirectional Mendelian randomization study
Wang, J., Fiori, P. L., Capobianco, G., Carru, C., & Chen, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1275419 · Cited by 8
Polycystic Ovarian Syndrome and Female Infertility
Naqvi, S. M. A. S., Bhattarai, J. B., Li, H., & Wang, X. W. (2019) · Yangtze Medicine · doi:10.4236/ym.2020.41002 · Cited by 9
The management of infertility for primary care physicians
de Souza, M. D. C. B., da Silva, L. A. B., Sequeira, F. F., Antunes, R. D. A., & de Souza, M. M. (2023) · Women & Health · doi:10.1080/03630242.2023.2165599 · Cited by 8
The Polycystic Ovary Syndrome (PCOS)
Louwers, Y. V., & Laven, J. S. E. (2020) · Endocrinology · doi:10.1007/978-3-030-14782-2_3 · Cited by 8
Self-citation
CTBP1‑AS upregulation is associated with polycystic ovary syndrome and can be effectively downregulated by cryptotanshinone
Wen, M., Dou, X., Zhang, S., Wang, B., Xu, J., Zhang, W., & Wang, F. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12761 · Cited by 8
House dust-derived mixtures of organophosphate esters alter the phenotype, function, transcriptome, and lipidome of KGN human ovarian granulosa cells
Wang, X., Rowan‐Carroll, A., Meier, M. J., Yauk, C. L., Wade, M. G., Robaire, B., & Hales, B. F. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae052 · Cited by 7
Periodontal and systemic health of morbidly obese patients eligible for bariatric surgery: a cross-sectional study
Čolak, D., Kučič, A. C., Pintar, T., Gašpirc, B., & Gašperšič, R. (2022) · BMC Oral Health · doi:10.1186/s12903-022-02207-0 · Cited by 9
Polycystic Ovarian Disease
Leon, L. I. R., Anastasopoulou, C., & Mayrin, J. V. (2021) · StatPearls · Cited by 7
CNOT6L regulates energy metabolism in the ovarian granulosa cells associated with polycystic ovary syndrome
Han, S., Xie, Y., Lv, J., Sun, X., & Shi, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1607161 · Cited by 6
Could polyphenols be an effective treatment in the management of polycystic ovary syndrome?
Irmak, E., Şanlıer, N. T., & Şanlıer, N. (2024) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000802 · Cited by 8
Exploring Serum Vitamin D, Sex Hormones, and Lipid Profile Disparities in Women With and Without Polycystic Ovarian Syndrome: A Case-Control Study
Akinola, L. A., Inyangudo, G. N., Ottun, A. T., Olumodeji, A. M., Adewunmi, A. A., Olalere, F. D. H., Omololu, O. M., & Ogungbemile, B. D. (2024) · Cureus · doi:10.7759/cureus.60975 · Cited by 6
Serum Levels of PDGF, EGF, and sFlt-1 in Patients with Polycystic Ovary Syndrome and Their Predictive Effects on Pregnancy Outcomes
Gao, J., Song, Y., Wang, D., Zhang, D., & Huang, X. L. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/7118464 · Cited by 6
Retracted
Vitamin D status among adolescent females with polycystic ovary syndrome
Pankiv, V. І., Yuzvenko, Т. Y., & Pankiv, І. V. (2022) · CHILD`S HEALTH · doi:10.22141/2224-0551.17.5.2022.1520 · Cited by 6
Reporting quality of polycystic ovary syndrome practice guidelines based on the RIGHT checklist
Li, H., Zhang, Y., Lu, L., & Wei, Y. (2020) · Medicine · doi:10.1097/md.0000000000022624 · Cited by 6
Effects of an “internet +” multidisciplinary management model oriented by nurse specialists on obesity combined with polycystic ovary syndrome
Ou, Y., Wu, L., Liu, L., Ye, X., Chen, Y., & Yuan, H. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5006125 · Cited by 5
Betaine alleviates letrozole-induced polycystic ovarian syndrome in rats by regulating oxidative stress and inflammation and restoring the proliferation-apoptosis balance
Babaeenezhad, E., Yegane, D. F., Yarahmadi, S., Fakouri, A., & Dezfoulian, O. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01826-9 · Cited by 5
The Polycystic Ovary Syndrome (PCOS)
Louwers, Y. V., & Laven, J. S. E. (2020) · Endocrinology · doi:10.1007/978-3-030-03594-5_3-1 · Cited by 6
Self-citation

Authors: Neven, A., Laven, J., Teede, H., & Boyle, J.
Affiliations: Erasmus MC (NL)
Monash University (AU)
Monash Medical Centre (AU)
Corresponding author: Boyle, Jacqueline
ORCID: Neven, Adriana
Laven, Joop
Teede, Helena
Boyle, Jacqueline
Venue: Seminars in Reproductive Medicine
Publisher: Georg Thieme Verlag KG
Published: 2018-01
Volume: 36
Issue: 01
Pages: 005-012
ISSN: 1526-4564 (ISSN-L)
1526-8004
DOI: 10.1055/s-0038-1668085
OpenAlex: W2891202838
Cited by: 196
References: 83
Citations by year: 2026: 9 · 2025: 22 · 2024: 29 · 2023: 32 · 2022: 43 · 2021: 35 · 2020: 18 · 2019: 8
FWCI: 2.30
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Seminars in Reproductive Medicine (publishedVersion)
PubMed (publishedVersion)
Monash University Research Portal (Monash University) (submittedVersion, other-oa)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders: National Health and Medical Research Council
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords: polycystic ovary syndrome, Rotterdam criteria, PCOS phenotypes, prevalence, delayed diagnosis, reproductive outcomes, metabolic complications, psychological factors, lifestyle intervention, PCOS management, evidence-based recommendations, quality of life
MeSH terms: Female, Humans, Infertility, Female, Life Style, Polycystic Ovary Syndrome, Prevalence, Symptom Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks